基于影像组学生物标志物预测肝细胞癌术后辅助TACE复发风险的多中心回顾性研究
该多中心回顾性研究纳入2014年11月至2023年5月接受术后辅助TACE的204例肝细胞癌患者,基于多参数MRI提取影像组学特征并构建模型,最优模型在训练组、内部验证组和外部验证组的C-index分别为0.828、0.796和0.718;高风险组无复发生存期在训练组和外部验证组均优于低风险组;联合列线图表现出更好的预测性能和临床净获益。
要点
- 基于多参数MRI的影像组学特征与肝细胞癌术后辅助TACE的复发风险相关。
- 最优影像组学模型(CoxBoost+survival-SVM)在三个队列的C-index为0.828、0.796和0.718。
- 联合列线图在训练集、内部验证集和外部验证集的C-index分别为0.848、0.825和0.722。
核心结论
- 基于多参数MRI的影像组学特征与接受术后辅助TACE的肝细胞癌患者复发风险相关,可能作为潜在影像生物标志物,用于筛选更可能从术后辅助TACE中获益的患者。
研究设计与样本
- 多中心回顾性研究,纳入三家中心2014年11月至2023年5月接受术后辅助TACE的204例肝细胞癌患者,分为训练组(n=91)、内部验证组(n=21)和外部验证组(n=92)。
诊断标准与关键数值
- 采用10种机器学习算法的101种组合构建影像组学模型,以平均C-index最高者(CoxBoost+survival-SVM)为最优模型,其C-index(95%CI)在训练组为0.828(0.777-0.879)、内部验证组为0.796(0.622-0.933)、外部验证组为0.718(0.647-0.781);联合列线图C-index(95%CI)在训练集为0.848(0.793-0.903)、内部验证集为0.825(0.689-0.962)、外部验证集为0.722(0.657-0.787);以Rad-score中位数将患者分为低风险组和高风险组。
临床应用与阅片要点
- 作者认为基于多参数MRI的影像组学特征可能作为潜在影像生物标志物,用于筛选更可能从术后辅助TACE中获益的肝细胞癌患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The study aims to evaluate the value of radiomics signature in predicting the recurrence risk in hepatocellular carcinoma (HCC) patients treated with postoperative adjuvant transarterial chemoembolization (PA-TACE).
PATIENTS AND METHODS: In this retrospective study, 204 HCC patients treated with PA-TACE between November 2014 and May 2023 from three centers were included and stratified into the training (n = 91), the internal(n = 21) and external validation cohorts (n = 92). Based on multi-parametric magnetic resonance imaging (mpMRI), radiomics features were extracted and radiomics models were established by using 101 combinations of 10 machine learning algorithms. The most valuable radiomics model with the highest average C-index was identified and subsequently used to calculate the Rad-score. All patients were then stratified into low- and high-risk radiomics signature (LRS and HRS) groups based on the median value of the Rad-score and subgroup analyses were performed to explore the potential association between recurrence risk and benefit from PA-TACE. Furthermore, a combined nomogram was subsequently developed by integrating the Rad-score with relevant clinicopathological variables.
RESULTS: The radiomics model developed by CoxBoost + survival-SVM method was regarded as the optimal model with C-index (95 % CI) of 0.828 (0.777-0.879), 0.796 (0.622-0.933), and 0.718 (0.647-0.781) in three cohorts. The RFS of the HRS group was superior to that of the LRS group in the training(52.4 months v.s. 27.5 months; P < 0.0001) and external validation cohorts(45.8 months v.s. 43.0 months; P < 0.0001). The combined nomogram presented better predictive performance in the training set (0.848, 0.793-0.903), internal validation (0.825, 0.689-0.962) and external validation (0.722, 0.657-0.787). The decision curve analysis indicated that the combined nomogram had relatively higher clinical net benefits.
CONCLUSION: mpMRI-based radiomics features are associated with recurrence risk in HCC patients receiving PA-TACE and may serve as the potential imaging biomarkers for stratifying candidates who are more likely benefit from PA-TACE.
引用
- Zhou L, Zheng L, Zhang K, et al. Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective study. Eur J Radiol. 2025. PMID: 41033016. doi:10.1016/j.ejrad.2025.112442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。